Invasive Pneumococcal Disease in Children: A Case Series on Clinical Profile, Serotypes and Antibiotic Resistance from Southern India
Abstract
Invasive Pneumococcal Disease (IPD) is defined as the isolation of pneumococci from normally sterile sites, including blood, cerebrospinal fluid, pleural fluid, ascitic fluid and synovial fluid. Despite widespread vaccination, IPD continues to be a major public health concern worldwide. Studying antibiotic resistance in the context of emerging serotypes and vaccines for IPD is crucial for optimising clinical management, guiding vaccine strategies and forming public health policies. By understanding the interplay between serotype dynamics, antibiotic resistance and vaccination, researchers and healthcare professionals can better mitigate the impact of pneumococcal disease on global health. In this case series, the authors describe the clinical profile, serotypes and antibiotic resistance of five cases of IPD in the paediatric age group. All five children exhibited severe signs of IPD, such as meningitis or septicaemia. The serotypes identified were 15C (2 cases), 6B, 19F and 23F. All five cases were sensitive to chloramphenicol, vancomycin, linezolid and levofloxacin. All cases were resistant to penicillin, and only one case was sensitive to erythromycin; all others were resistant. Cefotaxime was sensitive in three cases and intermediate in two cases. Cotrimoxazole was resistant in three cases, sensitive in one and intermediate in another case. The currently available Pneumococcal Conjugate Vaccine (PCV) offer substantial protection against IPD, but the occurrence of severe…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.